Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
20
|
pubmed:dateCreated |
1994-11-3
|
pubmed:abstractText |
Tumorigenesis is a multistep genetic process requiring several somatic mutations for neoplastic transformation. These mutations appear to be sequential, random, and independent events. However, we find linked, nonrandom ras mutations occurring during 4-nitroquinoline-1-oxide-induced tumorigenesis months after exposure to the carcinogen had ceased. The carcinogen had been topically applied to the oral cavity of CBA mice for 4 to 16 weeks. Dysplasia developed after 24 weeks, and carcinoma in situ and squamous cell carcinoma developed after 28 weeks. H-ras mutations were detected in 13 of 25 tissue specimens (10 of 14 invasive carcinomas and 2 of 4 carcinoma in situ, 1 of 5 dysplastic tissue, and 0 of 2 normal tissues). Approximately one-half of the tumors had G to A point mutations at codon 12 of the cellular H-ras proto-oncogene on mouse chromosome 7. None had codon 11, 13, or 61 mutations. Loss of heterozygosity occurred in 5 of 14 invasive cancers. Larger invasive squamous cell carcinomas consistently lost the wild-type allele, whereas preneoplastic lesions and small tumors were heterozygous for ras. This suggests a causal relationship between carcinogen treatment, H-ras activation, and initiation of tumorigenesis. The wild-type allele in mouse chromosome 7 is lost with the progression of tumorigenesis long after exposure to the carcinogen. Thus, loss of heterozygosity of the ras gene appears to occur without multiple carcinogen-induced mutations, i.e., as a result of a cascade of events induced by an earlier ras mutation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
54
|
pubmed:geneSymbol |
H-ras
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5310-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7923158-4-Nitroquinoline-1-oxide,
pubmed-meshheading:7923158-Animals,
pubmed-meshheading:7923158-Base Sequence,
pubmed-meshheading:7923158-Carcinoma, Squamous Cell,
pubmed-meshheading:7923158-Codon,
pubmed-meshheading:7923158-DNA Mutational Analysis,
pubmed-meshheading:7923158-Female,
pubmed-meshheading:7923158-Genes, ras,
pubmed-meshheading:7923158-Mice,
pubmed-meshheading:7923158-Mice, Inbred CBA,
pubmed-meshheading:7923158-Molecular Sequence Data,
pubmed-meshheading:7923158-Mouth Neoplasms,
pubmed-meshheading:7923158-Point Mutation,
pubmed-meshheading:7923158-Polymorphism, Restriction Fragment Length
|
pubmed:year |
1994
|
pubmed:articleTitle |
Harvey ras (H-ras) point mutations are induced by 4-nitroquinoline-1-oxide in murine oral squamous epithelia, while squamous cell carcinomas and loss of heterozygosity occur without additional exposure.
|
pubmed:affiliation |
Department of Biochemistry, Henry Vogt Research Institute of the James Graham Brown Cancer Center, University of Louisville, Kentucky.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|